Primer: Roche Holding (RO SE) - Aug 2026
Roche's unique integration of Pharmaceuticals and Diagnostics provides a distinct competitive advantage, enabling a personalized healthcare...
97 Views
Primer: Roche Holding (ROG SE) - Aug 2026
Roche's integrated business model, combining a dominant pharmaceuticals division with a leading diagnostics unit, provides a significant...
96 Views
Novartis Strikes for Possible Myelofibrosis Blockbuster
Novartis offers premium for MorphoSys AG in a bet on pelabrisib as a potential blockbuster for myelofibrosis treatment. Shareholders are likely to...
460 Views
[2026 Outlook] Pharma/BiotechIdentifying Leaders Within an Outperforming Sector
In 1H25, US policy uncertainty—i.e., potential drug tariffs, the most-favored-nation (MFN) pricing proposal, and Inflation Reduction Act (IRA) drug...
358 Views
Liquid Universe of European Ordinary and Preferred Shares: September '26 Report
September brought fresh dispersion: Carlsberg, Grifols and MFE widened sharply, improving convergence returns, while Ericsson's B-only buyback adds...
94 Views